Mucinex

FAQ/Help down arrow

Home down arrow

Contact Us down arrow

News down arrow

Respiratory Congestion
Mucociliary System
Pathophysiology
Management
Antibiotics
Treatment Options
Societal and Economic Impact
Related Links

Respiratory Information for Health Care Professionals

Welcome to your Web site

  • The MUCINEX brands are committed to providing health care professionals with relevant information on the respiratory tract and related therapies
  • This Web site contains resources and information to help you provide symptom relief of respiratory congestion for your patients
  • Please explore our Web site and plan to visit often to take advantage of periodic updates

Reference: 1. LaForce C, Gentile DA, Skoner DP. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections. Postgrad Med. 2008;120(2):1-7.

News & Conventions

Please visit us at the Reckitt Benckiser MUCINEX Booth

Click here for news on MUCINEX - the ONLY 12-hour, FDA-approved extended-release guaifenesin

Click here for our 2010 medical convention schedule

Patient Profiles

patients

Match the MUCINEX Product to the Patient

Click here for profiles of different types of congested patients


mucinex d helps patients feel better

Review the results of adding MUCINEX D as an adjunct to an antibiotic in the treatment of ARI

For access to the study published in Postgraduate Medicine, click here.

MUCINEX in. mucus out.